AstraZeneca PLC (OTCMKTS:AZNCF) Short Interest Update

AstraZeneca PLC (OTCMKTS:AZNCF) was the target of a large increase in short interest in the month of February. As of February 28th, there was short interest totalling 446,500 shares, an increase of 38.4% from the February 13th total of 322,700 shares. Based on an average trading volume of 4,500 shares, the short-interest ratio is presently 99.2 days.

AstraZeneca Stock Performance

AZNCF opened at $153.56 on Monday. The stock’s 50 day simple moving average is $143.21 and its 200 day simple moving average is $144.16. AstraZeneca has a 1-year low of $120.64 and a 1-year high of $175.00.

AstraZeneca Increases Dividend

The company also recently declared a dividend, which will be paid on Monday, March 24th. Investors of record on Friday, February 21st will be issued a $2.10 dividend. The ex-dividend date is Wednesday, February 19th. This is a boost from AstraZeneca’s previous dividend of $1.00. AstraZeneca’s dividend payout ratio is currently 343.14%.

About AstraZeneca

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.